Virchow’s triad is a framework describing three broad factors that promote thrombosis, the formation of a blood clot within the circulation: injury or dysfunction of the vessel lining, abnormal blood flow, and an increased tendency of blood to clot. It is particularly useful for explaining venous thrombosis, although its principles also apply to clot formation in arteries and the heart. The three factors interact; they are not separate diagnostic criteria, and all three need not be demonstrable for thrombosis to occur.
The three components
Endothelial injury or dysfunction
The vascular endothelium is the cellular lining of blood vessels. Under normal conditions, it helps maintain blood fluidity by limiting platelet activation and coagulation and supporting the breakdown of fibrin, the protein framework of a clot.
Physical damage can expose underlying material that promotes platelet adhesion and activation of blood coagulation. Endothelial cells can also become prothrombotic without being physically stripped away: inflammatory signals can alter their expression of anticoagulant, procoagulant, and cell-adhesion molecules.
Examples include vessel injury during trauma or surgery, irritation associated with intravascular catheters, and vascular changes accompanying inflammation. In arteries, disruption or erosion of an atherosclerotic plaque can trigger thrombus formation.
Abnormal blood flow
The flow component includes both stasis, meaning markedly slowed or stagnant blood flow, and disturbed flow, including turbulence.
Normal flow helps dilute and remove activated clotting factors and brings circulating inhibitors into contact with them. Stasis reduces this clearance and can promote local conditions that activate the endothelium. It is especially relevant in deep veins, including the pockets around venous valves.
Examples include reduced venous flow during prolonged immobility, impaired circulation associated with heart failure, and local obstruction of venous drainage. In atrial fibrillation, ineffective atrial contraction promotes stasis, particularly in the left atrial appendage. Disturbed flow around vascular abnormalities or diseased heart valves can also contribute to thrombosis.
Hypercoagulability
Hypercoagulability is an increased tendency of blood to form clots because of inherited or acquired changes in the haemostatic system.
Inherited contributors include factor V Leiden, the prothrombin G20210A variant, and deficiencies of the natural anticoagulants antithrombin, protein C, or protein S. Acquired contributors include cancer, pregnancy and the postpartum period, antiphospholipid syndrome, and exposure to certain oestrogen-containing medicines.
These conditions act through different mechanisms. Some increase procoagulant activity; others impair natural anticoagulant pathways or involve immune-mediated activation of cells and coagulation.
How the components interact
The triad is a model of interacting mechanisms rather than three independent causes. For example, major surgery can produce tissue and endothelial injury, reduced mobility can cause venous stasis, and the postoperative response can increase coagulation activity. Cancer can simultaneously alter coagulation, activate the endothelium, and obstruct venous flow.
The relative importance of each component varies by setting:
- Venous thrombosis: stasis and hypercoagulability are often prominent. Deep vein thrombosis commonly involves the deep veins of the legs or pelvis. Part of a thrombus may detach and travel to the pulmonary arteries, causing pulmonary embolism.
- Arterial thrombosis: vessel-wall disease and platelet activation are often prominent, particularly after plaque disruption. Such thrombosis can cause myocardial infarction or some forms of stroke.
- Intracardiac thrombosis: stasis and local tissue abnormalities can combine, as in atrial fibrillation or poorly contracting ventricular regions after myocardial injury.
Venous and arterial clots differ in their usual composition and haemodynamic setting, but the distinction is not absolute: platelets, coagulation proteins, blood cells, and endothelial responses contribute to both.
Historical background
The triad is named after the nineteenth-century German physician and pathologist Rudolf Virchow, whose investigations helped establish the relationship between venous thrombosis and embolism. The familiar three-part formulation developed through later interpretation and teaching; it should not be understood as a verbatim set of criteria originally stated by Virchow.
Clinical role and limitations
Virchow’s triad provides a structure for understanding thrombotic risk and organizing research into clot formation. It is not a diagnostic test, a validated numerical risk score, or a method for determining an individual’s absolute probability of thrombosis.
Its categories also overlap. Inflammation can affect the endothelium, alter flow locally, and increase coagulation activity at the same time. Modern accounts therefore supplement the triad with detailed mechanisms involving immune cells, platelets, fibrin breakdown, and interactions between blood and the vessel wall.